Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034993516> ?p ?o ?g. }
- W2034993516 endingPage "1798" @default.
- W2034993516 startingPage "1789" @default.
- W2034993516 abstract "Aim Many men diagnosed with localised prostate cancer will eventually be treated with androgen deprivation therapy (ADT). ADT is associated with adverse effects and its timing is controversial. Data on patterns of use are scarce. We describe patterns of ADT use, defined as castration (medical and surgical) or antiandrogen monotherapy initiated after primary treatment, in a population-based cohort. Methods and materials Data were extracted from the population-based Prostate Cancer data Base Sweden (PCBaSe). Totally 45,147 men diagnosed between 1997 and 2009 with clinical stage T1–2, N0–NX, M0–MX and prostate specific antigen (PSA) < 50 ng/ml without primary ADT were included. Outcomes in the period 2006 through 2010 were analysed using a period analysis approach. Results The cumulative incidence of castration at 10 years after diagnosis was 11.6% (95% confidence interval (CI), 11.0–12.2%). The corresponding proportion of antiandrogen monotherapy was 10.8% (95% CI, 10.2–11.4%). Castration was the dominant therapy among men on deferred treatment. The probability of receiving castration rather than antiandrogen monotherapy increased with age. Estimated median durations of castration ranged from 4 years in the deferred treatment high-risk group to 17 years in the prostatectomy low-risk group. The main limitation was the lack of information on progression to metastatic disease and PSA at the time for initiation of ADT. Conclusion When initiated early after curative treatment, the duration of castration can be decades. The findings indicate that more accurate tools are necessary to guide which men should be selected for ADT as secondary treatment." @default.
- W2034993516 created "2016-06-24" @default.
- W2034993516 creator A5001406891 @default.
- W2034993516 creator A5008797137 @default.
- W2034993516 creator A5010401322 @default.
- W2034993516 creator A5033731052 @default.
- W2034993516 creator A5054505998 @default.
- W2034993516 creator A5076457123 @default.
- W2034993516 date "2014-07-01" @default.
- W2034993516 modified "2023-10-11" @default.
- W2034993516 title "Patterns of androgen deprivation therapies among men diagnosed with localised prostate cancer: A population-based study" @default.
- W2034993516 cites W1982473888 @default.
- W2034993516 cites W1986114421 @default.
- W2034993516 cites W2003340521 @default.
- W2034993516 cites W2013136992 @default.
- W2034993516 cites W2013232728 @default.
- W2034993516 cites W2065616395 @default.
- W2034993516 cites W2071879495 @default.
- W2034993516 cites W2096149573 @default.
- W2034993516 cites W2103531329 @default.
- W2034993516 cites W2108864389 @default.
- W2034993516 cites W2112080888 @default.
- W2034993516 cites W2113791652 @default.
- W2034993516 cites W2115201106 @default.
- W2034993516 cites W2117299097 @default.
- W2034993516 cites W2120993630 @default.
- W2034993516 cites W2132508160 @default.
- W2034993516 cites W2142991244 @default.
- W2034993516 cites W2146061084 @default.
- W2034993516 cites W2158397011 @default.
- W2034993516 cites W2601961232 @default.
- W2034993516 cites W4249663626 @default.
- W2034993516 doi "https://doi.org/10.1016/j.ejca.2014.03.279" @default.
- W2034993516 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24736041" @default.
- W2034993516 hasPublicationYear "2014" @default.
- W2034993516 type Work @default.
- W2034993516 sameAs 2034993516 @default.
- W2034993516 citedByCount "17" @default.
- W2034993516 countsByYear W20349935162014 @default.
- W2034993516 countsByYear W20349935162015 @default.
- W2034993516 countsByYear W20349935162016 @default.
- W2034993516 countsByYear W20349935162017 @default.
- W2034993516 countsByYear W20349935162018 @default.
- W2034993516 countsByYear W20349935162019 @default.
- W2034993516 countsByYear W20349935162020 @default.
- W2034993516 countsByYear W20349935162021 @default.
- W2034993516 crossrefType "journal-article" @default.
- W2034993516 hasAuthorship W2034993516A5001406891 @default.
- W2034993516 hasAuthorship W2034993516A5008797137 @default.
- W2034993516 hasAuthorship W2034993516A5010401322 @default.
- W2034993516 hasAuthorship W2034993516A5033731052 @default.
- W2034993516 hasAuthorship W2034993516A5054505998 @default.
- W2034993516 hasAuthorship W2034993516A5076457123 @default.
- W2034993516 hasConcept C120665830 @default.
- W2034993516 hasConcept C121332964 @default.
- W2034993516 hasConcept C121608353 @default.
- W2034993516 hasConcept C126322002 @default.
- W2034993516 hasConcept C126894567 @default.
- W2034993516 hasConcept C143998085 @default.
- W2034993516 hasConcept C197934379 @default.
- W2034993516 hasConcept C2777899217 @default.
- W2034993516 hasConcept C2779256933 @default.
- W2034993516 hasConcept C2779322244 @default.
- W2034993516 hasConcept C2779466945 @default.
- W2034993516 hasConcept C2780192828 @default.
- W2034993516 hasConcept C2908647359 @default.
- W2034993516 hasConcept C29456083 @default.
- W2034993516 hasConcept C61511704 @default.
- W2034993516 hasConcept C71315377 @default.
- W2034993516 hasConcept C71924100 @default.
- W2034993516 hasConcept C72563966 @default.
- W2034993516 hasConcept C88879693 @default.
- W2034993516 hasConcept C99454951 @default.
- W2034993516 hasConceptScore W2034993516C120665830 @default.
- W2034993516 hasConceptScore W2034993516C121332964 @default.
- W2034993516 hasConceptScore W2034993516C121608353 @default.
- W2034993516 hasConceptScore W2034993516C126322002 @default.
- W2034993516 hasConceptScore W2034993516C126894567 @default.
- W2034993516 hasConceptScore W2034993516C143998085 @default.
- W2034993516 hasConceptScore W2034993516C197934379 @default.
- W2034993516 hasConceptScore W2034993516C2777899217 @default.
- W2034993516 hasConceptScore W2034993516C2779256933 @default.
- W2034993516 hasConceptScore W2034993516C2779322244 @default.
- W2034993516 hasConceptScore W2034993516C2779466945 @default.
- W2034993516 hasConceptScore W2034993516C2780192828 @default.
- W2034993516 hasConceptScore W2034993516C2908647359 @default.
- W2034993516 hasConceptScore W2034993516C29456083 @default.
- W2034993516 hasConceptScore W2034993516C61511704 @default.
- W2034993516 hasConceptScore W2034993516C71315377 @default.
- W2034993516 hasConceptScore W2034993516C71924100 @default.
- W2034993516 hasConceptScore W2034993516C72563966 @default.
- W2034993516 hasConceptScore W2034993516C88879693 @default.
- W2034993516 hasConceptScore W2034993516C99454951 @default.
- W2034993516 hasFunder F4320321491 @default.
- W2034993516 hasIssue "10" @default.
- W2034993516 hasLocation W20349935161 @default.
- W2034993516 hasLocation W20349935162 @default.
- W2034993516 hasOpenAccess W2034993516 @default.